| 
              
             | 
         
        
          
          
              
                
                    
                  | 
 American Society of Interventional Pain Physicians News  | October 22, 2014 
 |  
  | 
               
              
                 | 
               
              
                
                
                    
                      
                         
                         
                         
FDA Meeting on Epidural Steroid Use and How You Can Get Involved 
  
On November 24-25, 2014 the FDA Anesthetic and Analgesic Drug Products Advisory Committee Meeting will hold a meeting to discuss the risk of serious neurologic adverse reactions associated with epidural steroid injections (ESI) administered to reduce inflammation for pain management. The committee will also consider the efficacy of ESI and the overall risk benefit balance of injecting steroids in the epidural space to treat pain. The outcome of this meeting will determine future regulatory options, including but not limited to changes to the product labeling. This FDA hearing could be the greatest threat to IPM than anything we have faced in the past. 
  
You can get involved in two ways: 
- The most critical is support from patients with letters by Nov. 7, 2014.
 - Attend the FDA meeting on November 24
  
ASIPP is attempting to secure time to present our views; however, we will not know the time allocated to us until October 31st. If you would like to submit your own request to speak, you may do so by October 30th. Request may be submitted via e-mail to:     
  
Stephanie L. Begansky, PharmD 
Center for Drug Evaluation and Research 
Food and Drug Administration 
10903 New Hampshire Avenue 
WO31-2417 
Silver Spring, MD  20993-0002 
E-mail: AADPAC@fda.hhs.gov 
  
It is our understanding that several pain organizations and other societies such as ASA, PMR, etc., will also be presenting both pro and con views. In addition and most importantly, there are many patient groups such as the Arachnoiditis Association, which may be presenting in opposition to epidural injections. 
  
Because of this, it is crucial to obtain as many patient letters and send them to the FDA via our Capwiz link. 
  
Time is of the essence. The comments must be sent by November 7th so you should start today and continue sending through November 7. 
  
  
How to Get Patients  Letters Signed and Submitted  
  
1. Print off the  sample Patient  Letter. 
2. Ask the patients  to sign the letter as they check in. You can also include the patients'  drivers. 
3. Assign staff to  enter the patients' letters using the Capwiz letter link:  
4. If the patient  does not provide an email address, you can use your practice's  email. 
5. All letters  should be entered daily and any letters signed on Nov. 7 must be entered by COB  that day.  
  
The following information has been published thus far on epidural injections, FDA warning of epidural injections and other developments: 
  
ASIPP's FDA Citizen Petition requesting the Commissioner to withdraw the present Safety Warning. 
  
Pain Physician Journal Health Policy Opinion: Epidural Steroid Injections Safety Recommendations by the Multi-Society Pain Workgroup (MPW): More Regulations Without Evidence or Clarification 
  
Pain Physician Journal Health Policy Review: Epidural Steroid Warning Controversy Still Dogging FDA: 
  
Pain Physician Journal Letter to the Editor: The Food and Drug Administration's Recent Action on April 23, 2014 Failed to Appropriately Address Safety Concerns about Epidural Steroid 
 
 Work group passes epidural steroid injection consensus in response to FDA warning. Healio Spine Surgery, August 1, 2014   Recommendations for safe use of epidural steroid injections presented at the ASA 2013 annual meeting as part of FDA's Safe Use Initiative   American Society of Anesthesiologists. ASA Formally responding to FDA warning on injection of corticosteroids into epidural space, July 14, 2014.     International Spine Intervention Society. Update on ISIS Response to FDA Statement on ESIs.   The open public portion of the meeting will take place on Monday, November 24 from 8:00 a.m. to 5:00 p.m. If you would like to attend you would need to arrive on Sunday and could leave Monday afternoon and there are numerous hotels available in the area. The meeting location is:   FDA White Oak Campus Building 31 The Great Room (Rm. 1503) White Oak  Conference Center 10903 New Hampshire Avenue Silver Spring, Maryland   It is crucial that we have good representation at the meeting. If you are planning to attend please let us know.    |  
  
Pain Physician Journal Receives Impact Factor of 4.766
 
  
The American Society of Interventional Pain Physicians'  Pain Physician journal has received an Impact Factor of 4.766 in the 2014 release of the  Thomson Reuters Journal Citation Reports. 
  
Below you will find a list of Impact Factors for journals in the same field of interest as Pain Physician journal. 
  
   Journal Title                                        Impact Factor 
Pain Physician                                       4.76 
Pain Practice                                            2.183 
Pain Medicine                                          2.243 
Spine                                                        2.447 
Pain                                                          5.836 
J of Neurointerventional Surgery             2.495 
Spine journal                                            2.8 
Journal of Pain                                         2.737 
Clinical J of Pain                                      2.703 
Regional Anesthesia & Pain Medicine     2.12 
J. of Pain & Symptom Management        2.737 
J of Spine Disorders & Tech                    1.888 
Anesthesiology                                        6.168 
Anesthesia & Analgesia                          3.422 
Pain                                                         5.836 
Current Pain and Headache Reports      2.256 
Pain Research and Management            1.39 
Journal of Headache and Pain                3.281 
  
  
As you can see, this is a great accomplishment for our journal and it is in part because of you and the hard work you do serving on the editorial board, as section editors, as reviewers, as authors and even as promotors of journal articles. 
  
 |  
  
Companies Try to Escape Health Law's Penalties  
  
With companies set to face fines next year for not complying with the new mandate to offer health insurance, some are pursuing strategies like enrolling employees in Medicaid to avoid penalties and hold down costs.  
   
The health law's penalties, which can amount to about $2,000 per employee, were supposed to start this year, but the Obama administration delayed them until 2015, when they take effect for firms that employ at least 100 people.  
   
Now, as employers race to find ways to cover their full-time workers while holding a lid on costs, insurance brokers and benefits administrators are pitching a variety of options, sometimes exploiting wrinkles in the law. 
  
  
Wall Street Journal 
  
Access to this article may be limited. 
 |  
  
A recent poll shows that most doctors give Obamacare low grades - but should this influence voters' evaluation of the program? 
 
  
A recent survey of doctors by the Physicians Foundation finds that most give low grades to Obamacare. Some 46% of the doctors polled gave Obamacare a grade of "D" or "F" and 29% gave it a "C." Only 25 percent give it an "A" or a "B," including just 4% who gave it the highest grade. It's possible that some of the doctors who chose C really meant to say that it was at least reasonably good. But in modern America, thanks to grade inflation, a C is generally considered a very bad grade. Thus, it seems likely that a large majority of doctors have strongly negative view of the program. 
  
  
  
Washington Post
  |  
  
New doctors site rates for experience, quality 
 
  
The first comprehensive physician rating and comparison database launches Monday in time for open enrollment on federal and state health exchanges, as well as for many employer-provided plans. 
   
The new version of the website Healthgrades.com uses about 500 million claims from federal and private sources and patient reviews to rate and rank doctors based on their experience, complication rates at the hospitals where they practice and patient satisfaction. 
  
The new way to find the best doctor comes at a time when many health insurance plans offer fewer choices of doctors and hospitals. Users can sort and compare physicians based on where they live and their insurance plans. 
  
USA Today 
 |  
  
Blog: Figures Don't Lie But Liars Figure--Will There Be Some Obamacare Rate Shock in 2015? 
 
  
Hanging around actuaries as long as I have one of the old sayings I picked up was, "Figures don't lie, but liars figure."    I have read one story after another this summer and fall about the modest Obamacare rates increases--or decreases--for 2015.    On this blog you have also seen me write about the complex way the 2015 Obamacare rates will hit people particularly because of the impact the changes in the so called second lowest cost Silver plan will have on so many people's final subsidy. You have also seen me write about the fact that we really won't know what Obamacare costs people until the now unlimited Obamacare reinsurance program stops subsidizing insurance rates in 2017. 
  
Health Policy and Market Place
  |  
 
  Ebola: CDC Tightens Protection Rules 
   Faced with dismay over the Ebola infection of two nurses, the CDC has tightened its guidance for personal protective equipment.   
 The new guidelines "provide an increased margin of safety" for healthcare workers treating Ebola patients, according to CDC Director Tom Frieden, MD.   
 As first reported by MedPage Today, healthcare professionals had found the former guidance inadequate and incomplete, and many were angry that the CDC appeared to blame the two infected nurses for errors in using their equipment.     MedPage Today        |  
 | 
  Dr. Devi Asked to Speak on Ebola  Issue with Various Media Outlets 
  
   Below you will find just a sampling of interviews that Dr. Devi Nampiaparampil has done on the Ebola Issue. For a complete list of Dr. Devi's interviews, go to: http://doctordevi.com/ 
  
October 7: Ebola vs. Flu: What Should You Be Concerned About 
Fox News 
"The Real Story with Gretchen Carlson" 
http://video.foxnews.com/v/3825895537001/ebola-vs-flu-what-should-you-be-concerned-about/#sp=show-clips 
  
October 14: WHO-- Nearly 9000 Ebola Cases in W. Africa 
NOW With Alex Wagner 
MSNBC 
http://www.msnbc.com/now/watch/who--nearly-9-000-ebola-cases-in-w.-africa-342508611660 
  
  
October 16: CDC Grilled About Ebola 
CNN Newsroom with Brooke Baldwin 
CNN 
https://www.youtube.com/watch?v=iRIQiZpAKGI&feature=youtu.be 
  
  
October 16: Congressional Hearing on Ebola 
NOW with Alex Wagner 
MSNBC 
http://youtu.be/GT4NUn-4Fpg 
  
October 17: WHO Admits Botched Response to Ebola 
The Daily Rundown with Craig Melvin 
MSNBC 
http://www.msnbc.com/daily-rundown/watch/who-admits-botched-response-to-ebola-344075331637 
  
  
October 17: Here's How Ebola Spreads Among Health Workers 
Politics Nation with Rev. Al Sharpton 
MSNBC 
http://www.msnbc.com/politicsnation/watch/heres-how-ebola-spreads-among-health-workers-344372291787 
  
  
October 17: An Ebola Czar Is Appointed 
CNN Tonight with Don Lemon 
CNN 
https://www.youtube.com/watch?v=0EMLIWVqNL0 
  
  
October 19: Ebola in America  
A Fox News Special 
Fox News Channel 
https://www.youtube.com/watch?v=YSs948nmMxc&feature=youtu.be 
  
 |  
  
FDA approves labeling with abuse-deterrent features for third extended-release opioid analgesic  
   
   The U.S. Food and Drug Administration today approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release (ER) capsules, an opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Embeda is the third ER opioid analgesic to be approved with labeling describing the product's abuse-deterrent properties consistent with the FDA's 2013 draft guidance, Abuse-Deterrent Opioids - Evaluation and Labeling. The new labeling includes a claim indicating that Embeda has properties that are expected to reduce oral abuse when the product is crushed.  
  
FDA 
  
 |  
 | 
  ASIPP Resident/Fellow Governing Counseling Seeking Officer Nominations 
  
Interested in pursuing a career in pain management? Want to advocate on behalf of your profession and patients? Trying to distinguish yourself from other fellowship applicants? Enjoy networking with prominent members of your profession? Want to learn about prominent issues in pain medicine? 
  
If you answered "yes" to any of these, consider joining the American Society of Interventional Pain Physicians (ASIPP) and serving as a member of the Residents and Fellows (RFS) Governing Council. The Governing Council will be tasked with creating content recommendations for this year's annual conference and improving resident and fellow membership in ASIPP.  
  
We are soliciting nominations for the following positions (one year term): 
  
Chair- directs the section and implements the agenda as outlined by the board 
Vice Chair- assists the chair and lead membership recruitment  
Secretary - responsible for accurate record keeping of the section activities  
Member At-large - responsible for arranging RFS activities at the annual meeting 
Treasure - responsible for accurate financial management of funding designated to the section  
  
Please submit your CV and a 250 word maximum statement of interest to sunnyjha@gmail.com by October 31st. You can express interest in any and all positions.  
  
Governing Council members must be members of ASIPP, members of an accredited residency and/or fellowship program but must commit to attending the ASIPP Annual Meeting April 9-11 in Orlando, FL. ASIPP offers drastically reduced registration fees for the meeting to residents, fellows, and medical students. Governing Council members receive complimentary registration.  
  
Joining ASIPP as a resident and fellow is free and is easy, simply go to www.asipp.org and follow the links. 
   
 |  
 | 
  Register Today for ICD-10 Preparation Webinar Set for Nov. 4 
    
WEBINAR HIGHLIGHTS  
- Background on ICD-10 
 - Technology readiness to make      sure the products are ready 
 - The new 'Road to 10' tool to      create a custojmized action plan for ICD-10 
 - Key steps to ensure a      successful transition 
 - Resources to help with a smooth      implementation 
 - Discover the top ICD-10 areas      likely requiring documentation updates for pain management providers 
 - Technology readiness to make sure the products      are ready 
 - What are the testing procedures needed with      payers 
 - Practice determining the      correct ICD-10 diagnosis codes in common pain management conditions
  
  
WEBINAR FEE:   $175      
WEBINAR DATE: November 4, 2014   
TIME:   11:00am-12:30am CST 
CREDIT HOURS: 1.5 CEUs 
LENGTH: 90 Minutes 
SPEAKER: 
Marvel J Hammer, RN, BS, CPC, CCS-P,  ACS-PM, CPCO    
  
Click HERE to register: 
  
  
 |  
  
The Promise and Peril of ACOs  
  
A sleeping dragon awakes. 
   
At our weekly health policy colloquium yesterday, the presenter described plans for our organization to form its own accountable care organization, or ACO. 
   
The idea behind an ACO is to find patients who get the majority of their primary care within our system, and then "attribute" their healthcare and all of its attendant costs to that system, making the providers ultimately responsible for providing both high-quality and cost-efficient healthcare. 
  
  
MedPage Today 
  
 |  
  
Data quality killed my analytics program  
  
Improving the health of at-risk, vulnerable and chronically sick populations remains a massive challenge for healthcare organizations' financial administrators. Social, cultural, hereditary, economic and geographical issues not only stand in the way of traditional approaches to care, but also complicate efforts at controlling medical costs. 
   
In order to properly manage complex populations, comprehensive and reliable data on patient health and demographics are required. However, many players in the healthcare ecosystem have only a limited or imprecise understanding of the populations in their care. 
  
  
Healthcare Finance News 
  
  
 |  
  
CMS extends ACO fraud and abuse waivers  
  
Last week the Department of Health and Human Services Office of Inspector General and the Centers for Medicare & Medicaid Services published a joint notice continuing the effectiveness of fraud and abuse law waivers granted in 2011 in connection with the Medicare Shared Savings Program, which is intended to encourage physicians, hospitals, and certain other types of providers and suppliers to form accountable care organizations (ACOs). 
   
By way of background, in a November 2, 2011, joint OIG-CMS interim final rule with comment period, the agencies established waivers of the application of the federal physician self-referral law, the federal anti-kickback statute, and certain civil monetary penalties law provisions to specified arrangements involving ACOs participating in the Shared Savings Program (the Waiver IFC). 
  
  
Healthcare Finance News 
 |  
  
CCI 4th Quarter Updates Now Available 
  
These new edits have been effective since 10/1/2014 and will be effective through 12/31/2014. 
   
As a member benefit, we are providing you with the 4th quarter updates for IPM codes. 
   
For detailed analysis of NCCI for most commonly used interventional techniques, please follow the following link 
  
http://www.asipp.org/documents/CCIEditsOct2014.pdf
  |  
  | 
                     
                    | 
                
                  
                    
                    
                    
                   | 
               
              | 
         
        
           
Call for Abstracts! Make Plans Today to Participate in 17th Annual Meeting Abstract Session 
  
Make your plans now to participate in the American Society of Interventional Pain Physicians abstract and poster presentation at the 17th Annual Meeting, April 9-11 in Orlando  Florida. 
  
This year's abstract session will be bigger and better. In response to your many suggestions, the top 20 posters will be on  display through our new  electronic poster presentations with Q & A time with poster presenters. They will also be published in Pain Physician journal. 
  
In addition the Top 8 posters will be presented for judging during Friday's session. The top three abstracts will receive cash prizes. 
  
Posters will be on display during the meeting on both Thursday and Friday in the exhibitor hall. 
  
The abstract submission deadline will be February 6, 2015. 
  
  
For a complete set of rules and to access the online submission application, please go to:  http://www.asipp.org/0415-Abstract-registration.htm    
  
 |  
  State Society News
   
  
Save the Date: NY/NJ Chapters Schedule Pain Medicine Symposium 
  
The New York and New Jersey Societies of Interventional Pain Physicians' 2014 Pain Medicine Symposium will be held on November 6 - 9, 2014 at the Hyatt Regency Jersey City in New Jersey. 
  
More information will be available soon. 
 
  
* Please send your State Society meetings and news to:   Holly Long at hlong@asipp.org 
 
  
 |  
 | 
  Physicians Wanted 
  
To view or post a job, please go to: http://jobs.asipp.org/home 
  
to receive a member discount for posting a job, use member code: 20Member  
 |   
             | 
         
       
    	 |